|Articles|September 30, 2022
Bristol Myers Squibb and ConcertAI Announce Launch of Digital Clinical Trial Solution
Offering seeks to reduce or eliminate duplicative data entry and constant data monitoring.
Advertisement
ConcertAI announced the launch of its new Digital Trial Software-as-a-Service solution. Developed in partnership with Bristol Myers Squibb and powered by ConcertAI's real-world data, Digital Trial Solution integrates clinical research and clinical practice to simplify patient identification, consent, IRB approval, and contract negotiations.
Read more about the solution
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches
5